 LexaGene Holdings Inc said it has successfully expanded its biopharmaceutical contamination panel by developing a Burkholderia test for use on its MiQLab system. Burkholderia cepacia complex, a group of about 24 related environmental bacteria, is a problem contaminant for the biopharma industry. 